Anish Bhatnagar, CEO, Director at Soleno Therapeutics, holds 719.55K shares in Soleno Therapeutics (Ticker: SLNO). Most recently, Anish Bhatnagar Sold $21,633 shares of Soleno Therapeutics on Oct 03, 2024 for an estimated value of 1.07M.
What is the percentage of profitable transactions made by Anish Bhatnagar?
The percentage of profitable transactions made by Anish Bhatnagar is 8%.
What is the average return per transaction made by Anish Bhatnagar?
The average return per transaction made by Anish Bhatnagar is -37.30%.
What stocks does Anish Bhatnagar hold?
Anish Bhatnagar holds: SLNO stocks.
What was Anish Bhatnagar’s latest transaction?
Anish Bhatnagar latest transaction was an Informative Sell of $1.07M.
What was Anish Bhatnagar's most profitable transaction?
Anish Bhatnagar’s most profitable transaction was an Informative Sell of SLNO stock on January 25, 2022. The return on the trade was 52.80%.
What is Anish Bhatnagar's role in Soleno Therapeutics?
Anish Bhatnagar's role in Soleno Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.